---
title: "Harvard Bioscience reports strong Q4 results and optimistic outlook for 2026, lays out future strategies."
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/275465605.md"
description: "Harvard Bioscience has released an initial overview of its financial performance for the fourth quarter, with significant positive indicators for 2026. The company has highlighted a promising outlook for the upcoming year and outlined key areas of strategic focus for long-term growth. The specifics of the financial results and future projections were not disclosed. This update suggests that Harvard Bioscience is on track for a successful year ahead with a clear vision for sustained development."
datetime: "2026-02-10T13:02:47.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/275465605.md)
  - [en](https://longbridge.com/en/news/275465605.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/275465605.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/275465605.md) | [English](https://longbridge.com/en/news/275465605.md)


# Harvard Bioscience reports strong Q4 results and optimistic outlook for 2026, lays out future strategies.

Harvard Bioscience has released an initial overview of its financial performance for the fourth quarter, with significant positive indicators for 2026. The company has highlighted a promising outlook for the upcoming year and outlined key areas of strategic focus for long-term growth. The specifics of the financial results and future projections were not disclosed. This update suggests that Harvard Bioscience is on track for a successful year ahead with a clear vision for sustained development.

### 相關股票

- [Harvard Bioscience (HBIO.US)](https://longbridge.com/zh-HK/quote/HBIO.US.md)
- [VanEck Biotech ETF (BBH.US)](https://longbridge.com/zh-HK/quote/BBH.US.md)
- [ALPS Medical Breakthrough (SBIO.US)](https://longbridge.com/zh-HK/quote/SBIO.US.md)
- [iShares US Medical Devices (IHI.US)](https://longbridge.com/zh-HK/quote/IHI.US.md)
- [Invesco Biotechnology & Genome ETF (PBE.US)](https://longbridge.com/zh-HK/quote/PBE.US.md)
- [Proshares Ultra Nasdaq Biotech (BIB.US)](https://longbridge.com/zh-HK/quote/BIB.US.md)
- [First Trust NYSE Arca Biotech Index Fd (FBT.US)](https://longbridge.com/zh-HK/quote/FBT.US.md)
- [iShares Biotechnology ETF (IBB.US)](https://longbridge.com/zh-HK/quote/IBB.US.md)
- [SPDR S&P Health Equip (XHE.US)](https://longbridge.com/zh-HK/quote/XHE.US.md)
- [SPDR S&P Biotech (XBI.US)](https://longbridge.com/zh-HK/quote/XBI.US.md)

## 相關資訊與研究

- [bioAffinity Launches Major Lung Cancer Detection Study](https://longbridge.com/zh-HK/news/278565253.md)
- [Stryker Says Cyberattack Disruption Is Continuing](https://longbridge.com/zh-HK/news/278948331.md)
- [Harvard Bioscience Q4 revenue falls 3%, reports net loss](https://longbridge.com/zh-HK/news/278875728.md)
- [Capital International Ltd. CA Reduces Stock Position in Danaher Corporation $DHR](https://longbridge.com/zh-HK/news/278547205.md)
- [Thermo Fisher Scientific Inc. $TMO is Grantham Mayo Van Otterloo & Co. LLC's 9th Largest Position](https://longbridge.com/zh-HK/news/278257923.md)